Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 58


Hypoxia worsens the impact of intracellular triglyceride accumulation promoted by electronegative low-density lipoprotein in cardiomyocytes by impairing perilipin 5 upregulation.

Revuelta-López E, Cal R, Julve J, Rull A, Martínez-Bujidos M, Perez-Cuellar M, Ordoñez-Llanos J, Badimon L, Sanchez-Quesada JL, Llorente-Cortés V.

Int J Biochem Cell Biol. 2015 Aug;65:257-67. doi: 10.1016/j.biocel.2015.06.014. Epub 2015 Jun 19.


Increased concentration of clusterin/apolipoprotein J (apoJ) in hyperlipemic serum is paradoxically associated with decreased apoJ content in lipoproteins.

Rull A, Martínez-Bujidos M, Pérez-Cuellar M, Pérez A, Ordóñez-Llanos J, Sánchez-Quesada JL.

Atherosclerosis. 2015 Aug;241(2):463-70. doi: 10.1016/j.atherosclerosis.2015.06.003. Epub 2015 Jun 6.


Stevia-derived compounds attenuate the toxic effects of ectopic lipid accumulation in the liver of obese mice: a transcriptomic and metabolomic study.

Holvoet P, Rull A, García-Heredia A, López-Sanromà S, Geeraert B, Joven J, Camps J.

Food Chem Toxicol. 2015 Mar;77:22-33. doi: 10.1016/j.fct.2014.12.017. Epub 2014 Dec 29.


Clusterin/apolipoprotein J binds to aggregated LDL in human plasma and plays a protective role against LDL aggregation.

Martínez-Bujidos M, Rull A, González-Cura B, Pérez-Cuéllar M, Montoliu-Gaya L, Villegas S, Ordóñez-Llanos J, Sánchez-Quesada JL.

FASEB J. 2015 May;29(5):1688-700. doi: 10.1096/fj.14-264036. Epub 2014 Dec 30.


Understanding the role of circulating chemokine (C-C motif) ligand 2 in patients with chronic ischemia threatening the lower extremities.

Rull A, Hernandez-Aguilera A, Fibla M, Sepulveda J, Rodríguez-Gallego E, Riera-Borrull M, Sirvent JJ, Martín-Paredero V, Menendez JA, Camps J, Joven J.

Vasc Med. 2014 Dec;19(6):442-51. doi: 10.1177/1358863X14554034. Epub 2014 Oct 21.


Rosiglitazone and fenofibrate exacerbate liver steatosis in a mouse model of obesity and hyperlipidemia. A transcriptomic and metabolomic study.

Rull A, Geeraert B, Aragonès G, Beltrán-Debón R, Rodríguez-Gallego E, García-Heredia A, Pedro-Botet J, Joven J, Holvoet P, Camps J.

J Proteome Res. 2014 Mar 7;13(3):1731-43. doi: 10.1021/pr401230s. Epub 2014 Jan 30.


Ubiquitous transgenic overexpression of C-C chemokine ligand 2: a model to assess the combined effect of high energy intake and continuous low-grade inflammation.

Rodríguez-Gallego E, Riera-Borrull M, Hernández-Aguilera A, Mariné-Casadó R, Rull A, Beltrán-Debón R, Luciano-Mateo F, Menendez JA, Vazquez-Martin A, Sirvent JJ, Martín-Paredero V, Corbí AL, Sierra-Filardi E, Aragonès G, García-Heredia A, Camps J, Alonso-Villaverde C, Joven J.

Mediators Inflamm. 2013;2013:953841. doi: 10.1155/2013/953841. Epub 2013 Dec 15.


Paraoxonase-1 inhibits oxidized low-density lipoprotein-induced metabolic alterations and apoptosis in endothelial cells: a nondirected metabolomic study.

García-Heredia A, Marsillach J, Rull A, Triguero I, Fort I, Mackness B, Mackness M, Shih DM, Joven J, Camps J.

Mediators Inflamm. 2013;2013:156053. doi: 10.1155/2013/156053. Epub 2013 May 22.


A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study.

Fernández-Sender L, Alonso-Villaverde C, Rull A, Rodríguez-Gallego E, Riera-Borrull M, Hernández-Aguilera A, Camps J, Beltrán-Debón R, Aragonès G, Menendez JA, Joven J.

AIDS Res Ther. 2013 May 9;10(1):11. doi: 10.1186/1742-6405-10-11.


Mitochondrial dysfunction: a basic mechanism in inflammation-related non-communicable diseases and therapeutic opportunities.

Hernández-Aguilera A, Rull A, Rodríguez-Gallego E, Riera-Borrull M, Luciano-Mateo F, Camps J, Menéndez JA, Joven J.

Mediators Inflamm. 2013;2013:135698. doi: 10.1155/2013/135698. Epub 2013 Feb 28. Review.


Paraoxonase-1 deficiency is associated with severe liver steatosis in mice fed a high-fat high-cholesterol diet: a metabolomic approach.

García-Heredia A, Kensicki E, Mohney RP, Rull A, Triguero I, Marsillach J, Tormos C, Mackness B, Mackness M, Shih DM, Pedro-Botet J, Joven J, Sáez G, Camps J.

J Proteome Res. 2013 Apr 5;12(4):1946-55. doi: 10.1021/pr400050u. Epub 2013 Mar 8.


Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agents.

Menendez JA, Joven J, Aragonès G, Barrajón-Catalán E, Beltrán-Debón R, Borrás-Linares I, Camps J, Corominas-Faja B, Cufí S, Fernández-Arroyo S, Garcia-Heredia A, Hernández-Aguilera A, Herranz-López M, Jiménez-Sánchez C, López-Bonet E, Lozano-Sánchez J, Luciano-Mateo F, Martin-Castillo B, Martin-Paredero V, Pérez-Sánchez A, Oliveras-Ferraros C, Riera-Borrull M, Rodríguez-Gallego E, Quirantes-Piné R, Rull A, Tomás-Menor L, Vazquez-Martin A, Alonso-Villaverde C, Micol V, Segura-Carretero A.

Cell Cycle. 2013 Feb 15;12(4):555-78. doi: 10.4161/cc.23756. Epub 2013 Jan 31.


Metformin: a cheap and well-tolerated drug that provides benefits for viral infections.

Joven J, Menéndez JA, Fernandez-Sender L, Espinel E, Rull A, Beltrán-Debón R, Rodríguez-Gallego E, Riera-Borrull M, Pedro-Botet J, Alonso-Villaverde C, Camps J, Aragonès G.

HIV Med. 2013 Apr;14(4):233-40. doi: 10.1111/hiv.12000. Epub 2012 Nov 21.


Exploring PPAR modulation in experimental mice.

Rull A, Aragonès G, Beltrán-Debón R, Rodríguez-Gallego E, Camps J, Joven J.

Methods Mol Biol. 2013;952:253-73. doi: 10.1007/978-1-62703-155-4_19.


Multifunctional targets of dietary polyphenols in disease: a case for the chemokine network and energy metabolism.

Joven J, Rull A, Rodriguez-Gallego E, Camps J, Riera-Borrull M, Hernández-Aguilera A, Martin-Paredero V, Segura-Carretero A, Micol V, Alonso-Villaverde C, Menéndez JA.

Food Chem Toxicol. 2013 Jan;51:267-79. doi: 10.1016/j.fct.2012.10.004. Epub 2012 Oct 11. Review.


Monocyte chemoattractant protein-1 and paraoxonase-1 and 3 levels in patients with sepsis treated in an intensive care unit: a preliminary report.

Sans T, Rull A, Luna J, Mackness B, Mackness M, Joven J, Ibañez M, Pariente R, Rodriguez M, Ortin X, Masdeu G, Camps J.

Clin Chem Lab Med. 2012 Feb 1;50(8):1409-15. doi: 10.1515/cclm-2011-0896.


The deleterious influence of tenofovir-based therapies on the progression of atherosclerosis in HIV-infected patients.

Aragonès G, Pardo-Reche P, Fernández-Sender L, Rull A, Beltrán-Debón R, Rodríguez-Gallego E, Camps J, Joven J, Alonso-Villaverde C.

Mediators Inflamm. 2012;2012:372305. doi: 10.1155/2012/372305. Epub 2012 May 7.


Plant-derived polyphenols regulate expression of miRNA paralogs miR-103/107 and miR-122 and prevent diet-induced fatty liver disease in hyperlipidemic mice.

Joven J, Espinel E, Rull A, Aragonès G, Rodríguez-Gallego E, Camps J, Micol V, Herranz-López M, Menéndez JA, Borrás I, Segura-Carretero A, Alonso-Villaverde C, Beltrán-Debón R.

Biochim Biophys Acta. 2012 Jul;1820(7):894-9. doi: 10.1016/j.bbagen.2012.03.020. Epub 2012 Apr 5.


The level of DING proteins is increased in HIV-infected patients: in vitro and in vivo studies.

Djeghader A, Aragonès G, Darbinian N, Elias M, Gonzalez D, García-Heredia A, Beltrán-Debón R, Kaminski R, Gotthard G, Hiblot J, Rull A, Rohr O, Schwartz C, Alonso-Villaverde C, Joven J, Camps J, Chabriere E.

PLoS One. 2012;7(3):e33062. doi: 10.1371/journal.pone.0033062. Epub 2012 Mar 9.


Human Duffy blood group alloantigen system influences the measurement of monocyte chemoattractant protein-1 (MCP-1) in serum but not in plasma.

Aragonès G, Ercilla A, Barreda M, Rull A, Beltrán-Debón R, Rodríguez-Gallego E, Alonso-Villaverde C, Camps J, Joven J.

Clin Lab. 2012;58(1-2):185-8.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk